Research programme: monoclonal antibody-based therapeutics and diagnostics - multimmuneAlternative Names: mi-TUMEXdx; mi-TUMEXim; mi-TUMEXtx
Latest Information Update: 29 Jan 2016
At a glance
- Originator multimmune
- Class Diagnostic agents; Imaging agents; Monoclonal antibodies
- Mechanism of Action Diagnostic imaging enhancers; HSP70 heat-shock protein modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Colorectal cancer; Solid tumours
Most Recent Events
- 28 Jan 2016 Preclinical trials in Colorectal cancer in Germany (Parenteral)
- 28 Jan 2016 Preclinical trials in Solid tumours (Diagnosis) in Germany